Company: ZVRA
Filing Date: 2025-04-16
Form Type: PRRN14A
Source: 0000897069-25-000815
Chunk: 25

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-16
Form: PRRN14A
Chunk 25
---
 and broker non-votes will not have any effect on the outcome of the Proposal 1. Proposal 2: Ratification of the Appointment of EY –According to the Company’s proxy statement, matters (other than the election of directors) require the affirmative vote of the majority of shares present in person and entitled to vote on the matter.. Votes “ FOR” from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter will ratify Proposal 2. Abstentions and Broker non-votes will be considered votes against Proposal 2. 15 How are votes counted? According to the Company’s proxy statement, votes will be counted by the inspector of election appointed for the Annual Meeting. When are stockholder proposals and director nominations due for next year’s annual meeting? According to the Company’s proxy statement, stockholders who intend to have a proposal considered for inclusion in next year’s proxy materials for presentation at the Company’s 2026 annual meeting of stockholders pursuant to Rule 14a-8 under the Exchange Act must submit the proposal in writing by [●], 2025, to the Company’s Corporate Secretary at 1180 Celebration Boulevard, Suite 103, Celebration, FL 34747. If you wish to submit a proposal (including a director nomination) for presentation at the Annual Meeting that is not to be included in next year’s proxy materials, you must do so by [●], 2026, but no earlier than [●], 2025; provided, however that if next year’s annual meeting is advanced more than 30 days prior to or delayed by more than 30 days after [●], 2026, your proposal must be submitted (i) not earlier than the close of business on the 120th day prior to such annual meeting and not later than the close of business on the later of the 90th day prior to such annual meeting; or if later, (ii) the tenth day following the day on which public announcement of the date of such meeting is first made. You are also advised to review the Company’s Bylaws, which contain additional requirements about advance notice of stockholder proposals and director nominations. In addition to satisfying the requirements under the Company’s Bylaws, to comply with Rule 14a-19 under the Exchange Act, any stockholder who intends to solicit proxies in support of director nominees other than the Company’s nominees at the 2026 annual meeting of stockholders must provide written notice that sets forth the information